FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2488354037> ?p ?o ?g. }

• W2488354037 endingPage "e4459" @default.
• W2488354037 startingPage "e4459" @default.
• W2488354037 abstract "Background: Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis characterized by abrupt onset of hypertension, thrombotic microangiopathy, and kidney injury. The mechanisms of the disease remain ill-defined, but a growing body of evidence suggests that activation of the complement system may be involved. Methods: Here, we report the case of a patient presenting with severe SRC and strong evidence of complement activation, both in serum and in the kidney, in the absence of genetic defect of the complement system. Results: Immunofluorescence studies on kidney biopsy showed significant deposits of C1q and C4d in the endothelium of renal arterioles, pointing toward activation of the classical pathway. Because of the dramatic clinical and histological severity, and the lack of response to early treatment with angiotensin-converting enzyme inhibitors, calcium channel blockers and plasma exchange, the patient was treated with the specific C5 blocker eculizumab. Contrarily to conventional treatment, eculizumab efficiently blocked C5b-9 deposition ex vivo and maintained hematological remission. Unfortunately, the patient died from heart failure a few weeks later. Postmortem examination of the heart showed diffuse patchy interstitial fibrosis, the typical lesion of systemic sclerosis-related cardiomyopathy, but normal coronary arteries and myocardial microvasculature. Conclusion: SRC may lead to complement system activation through the classical pathway. Early administration of C5 inhibitor eculizumab may have therapeutic potential in patients with life-threatening SRC refractory to conventional treatment using angiotensin-converting enzyme inhibitors." @default.
• W2488354037 created "2016-08-23" @default.
• W2488354037 creator A5006016218 @default.
• W2488354037 creator A5008337621 @default.
• W2488354037 creator A5016171901 @default.
• W2488354037 creator A5025003426 @default.
• W2488354037 creator A5033806646 @default.
• W2488354037 creator A5035092043 @default.
• W2488354037 creator A5048364347 @default.
• W2488354037 creator A5051513022 @default.
• W2488354037 creator A5065092951 @default.
• W2488354037 creator A5086275620 @default.
• W2488354037 date "2016-07-01" @default.
• W2488354037 modified "2023-09-30" @default.
• W2488354037 title "Complement activation and effect of eculizumab in scleroderma renal crisis" @default.
• W2488354037 cites W1976386747 @default.
• W2488354037 cites W1978036778 @default.
• W2488354037 cites W2008458556 @default.
• W2488354037 cites W2028781819 @default.
• W2488354037 cites W2052981226 @default.
• W2488354037 cites W2060509574 @default.
• W2488354037 cites W2069540486 @default.
• W2488354037 cites W2070954196 @default.
• W2488354037 cites W2071493686 @default.
• W2488354037 cites W2076514240 @default.
• W2488354037 cites W2106914255 @default.
• W2488354037 cites W2123753762 @default.
• W2488354037 cites W2125266164 @default.
• W2488354037 cites W2125297646 @default.
• W2488354037 cites W2126092981 @default.
• W2488354037 cites W2142473767 @default.
• W2488354037 cites W2150297856 @default.
• W2488354037 cites W2179622030 @default.
• W2488354037 cites W2262125883 @default.
• W2488354037 doi "https://doi.org/10.1097/md.0000000000004459" @default.
• W2488354037 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5265879" @default.
• W2488354037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27472742" @default.
• W2488354037 hasPublicationYear "2016" @default.
• W2488354037 type Work @default.
• W2488354037 sameAs 2488354037 @default.
• W2488354037 citedByCount "55" @default.
• W2488354037 countsByYear W24883540372017 @default.
• W2488354037 countsByYear W24883540372018 @default.
• W2488354037 countsByYear W24883540372019 @default.
• W2488354037 countsByYear W24883540372020 @default.
• W2488354037 countsByYear W24883540372021 @default.
• W2488354037 countsByYear W24883540372022 @default.
• W2488354037 countsByYear W24883540372023 @default.
• W2488354037 crossrefType "journal-article" @default.
• W2488354037 hasAuthorship W2488354037A5006016218 @default.
• W2488354037 hasAuthorship W2488354037A5008337621 @default.
• W2488354037 hasAuthorship W2488354037A5016171901 @default.
• W2488354037 hasAuthorship W2488354037A5025003426 @default.
• W2488354037 hasAuthorship W2488354037A5033806646 @default.
• W2488354037 hasAuthorship W2488354037A5035092043 @default.
• W2488354037 hasAuthorship W2488354037A5048364347 @default.
• W2488354037 hasAuthorship W2488354037A5051513022 @default.
• W2488354037 hasAuthorship W2488354037A5065092951 @default.
• W2488354037 hasAuthorship W2488354037A5086275620 @default.
• W2488354037 hasBestOaLocation W24883540371 @default.
• W2488354037 hasConcept C111684460 @default.
• W2488354037 hasConcept C126322002 @default.
• W2488354037 hasConcept C142724271 @default.
• W2488354037 hasConcept C159654299 @default.
• W2488354037 hasConcept C203014093 @default.
• W2488354037 hasConcept C27016395 @default.
• W2488354037 hasConcept C2777878052 @default.
• W2488354037 hasConcept C2777991916 @default.
• W2488354037 hasConcept C2779134260 @default.
• W2488354037 hasConcept C2780091579 @default.
• W2488354037 hasConcept C71924100 @default.
• W2488354037 hasConcept C84393581 @default.
• W2488354037 hasConcept C90924648 @default.
• W2488354037 hasConceptScore W2488354037C111684460 @default.
• W2488354037 hasConceptScore W2488354037C126322002 @default.
• W2488354037 hasConceptScore W2488354037C142724271 @default.
• W2488354037 hasConceptScore W2488354037C159654299 @default.
• W2488354037 hasConceptScore W2488354037C203014093 @default.
• W2488354037 hasConceptScore W2488354037C27016395 @default.
• W2488354037 hasConceptScore W2488354037C2777878052 @default.
• W2488354037 hasConceptScore W2488354037C2777991916 @default.
• W2488354037 hasConceptScore W2488354037C2779134260 @default.
• W2488354037 hasConceptScore W2488354037C2780091579 @default.
• W2488354037 hasConceptScore W2488354037C71924100 @default.
• W2488354037 hasConceptScore W2488354037C84393581 @default.
• W2488354037 hasConceptScore W2488354037C90924648 @default.
• W2488354037 hasIssue "30" @default.
• W2488354037 hasLocation W24883540371 @default.
• W2488354037 hasLocation W24883540372 @default.
• W2488354037 hasLocation W24883540373 @default.
• W2488354037 hasLocation W24883540374 @default.
• W2488354037 hasLocation W24883540375 @default.
• W2488354037 hasOpenAccess W2488354037 @default.
• W2488354037 hasPrimaryLocation W24883540371 @default.
• W2488354037 hasRelatedWork W2014042242 @default.
• W2488354037 hasRelatedWork W2034286783 @default.
• W2488354037 hasRelatedWork W2140370443 @default.
• W2488354037 hasRelatedWork W2141534367 @default.

• next